Webcasts Event RSS

Upcoming Events Past Events

J.P. Morgan 39th Annual Healthcare Conference

January 13, 2021 03:40 PM EST

View the live Webcast

Presentation (PDF)

Piper Sandler 32nd Annual Virtual Healthcare Conference

November 25, 2020

View the Recording

Halozyme to Host Third Quarter 2020 Financial Results Conference Call

November 2, 2020 04:30 PM EST

View the live Webcast

Investor Materials

Thumb Date Download

May 20, 2020 Corporate Presentation 1.86 MB

April 8, 2020 2019 Annual Report 1.46 MB

January 1, 2018 2018 Annual Report 939 KB

December 31, 2017 2017 Annual Report 3.18 MB

July 24, 2016 2016 Annual Report 4.75 MB

July 23, 2016 2015 Annual Report 5.24 MB

July 21, 2016 2014 Annual Report 2.13 MB

Recent News

Date Title Press Release RSS

Halozyme Announces Janssen Receives FDA Approval Of DARZALEX FASPRO® (Daratumumab And Hyaluronidase-fihj) As Treatment For Newly Diagnosed Patients With Light Chain (AL) Amyloidosis 01/15/21

Halozyme Provides 2021 Financial Guidance Highlighted By Strong Revenue And EPS Growth 01/11/21

Halozyme To Present Virtually At The 39th Annual J.P. Morgan Healthcare Conference 01/04/21

Halozyme Announces Roche Receives European Commission Approval For Phesgo® (Fixed-Dose Combination Of Perjeta® And Herceptin® For Subcutaneous Injection) Utilizing Halozyme's ENHANZE® Technology For The Treatment Of Patients With HER2-Positive Breast Cancer 12/23/20

See More

Investor Contacts

Al Kildani
Vice President, Investor Relations
& Corporate Communications
Phone: 858-704-8122
Email: akildani@halozyme.com
media@halozyme.com
ir@halozyme.com

Useful Links

Copyright© 2015-2019. Halozyme, Inc. All rights reserved. All trademarks belong to their respective owners.

Powered By Q4 Inc. 5.49.0.3

Notice

You are now leaving Halozyme.com. Halozyme is not responsible for or endorses the content of the linked site.

Ok